Therapeutic effect of adjunctive 940nm diode laser photobiomodulation with carbamazepine on pain , infrared orofacial thermography and oral health quality of life in Trigeminal Neuralgia: A randomized clinical trial - NI

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.All new diagnosed cases of Trigeminal neuralgia as per ICHD-3 criteria reporting to the department of OMR, CDER and willing to participate in the study will be included
•2. Subjects diagnosed with Trigeminal neuralgia with a VAS score more than or equal to 5
•3. Subjects willing to complete the treatment sessions

•TN on polypharmacotherapy
•2.TN secondary to multiple sclerosis, tumor, CNS lesions, herpes zoster or any other causes other than oral surgery.
•3.TN in solely V1 distribution and acute TN
•4.Past invasive treatment (MVD, alcohol block, cryosurgery, radiofrequency thermocoagulation, glycerol rhizolysis, gamma knife and stereotactic radiosurgery etc.)
•5.Subjects with other orofacial pain like odontogenic/sinus/ occular otologic pain/ infection,TMD’s, myofascial pain , atypical orofacial pain, Burning mouth syndrome, traumatic neuropathy, or other neurological, psychiatric, neuromuscular and sensory disorders
•6.Subjects on anti-inflammatories, analgesics, anaesthetics or any other medication for neurological disorders
•7.Subjects with uncontrolled systemic diseases, with abnormal haemogram, liver function tests and renal function tests.
•8.Subjects with current or past history of malignancy.
•9.Alcoholics, drug addicts and patients with pacemaker.
•10.Subjects with scars, tattoos, moles, traumatic, ulcerative, pathological skin lesion, open wounds, ulcers, or inflammation on facial skin in V2, V3 distribution sites to be exposed to Laser PBMT.
•11.Subjects with bone marrow suppression, hypersensitivity to carbamazepine and tricyclic compounds
•12.Pregnant and lactating females

发起方